Ingerman M J, Santoro J
Medical College of Pennsylvania, Philadelphia.
Infect Dis Clin North Am. 1989 Sep;3(3):641-51.
Interest in vancomycin has been rekindled by the emergence of resistant gram-positive pathogens and the improvement in drug purity. The antimicrobial activity, pharmacokinetics, clinical indications, dosing schedules, and adverse reactions of vancomycin are summarized.
耐万古霉素革兰氏阳性病原体的出现以及药物纯度的提高,重新引发了人们对万古霉素的关注。本文总结了万古霉素的抗菌活性、药代动力学、临床适应症、给药方案及不良反应。